Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the US
Dima M. Qato, Jonathan H. Watanabe, Kelly James Clark
Abstract
This Viewpoint describes federal and state pharmacy regulations that may create barriers to buprenorphine access at pharmacies and suggests policy changes to address those barriers.
Topics & Concepts
BuprenorphinePharmacyBusinessState (computer science)MarketingMedicineFamily medicineOpioidComputer scienceReceptorAlgorithmInternal medicineOpioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPoisoning and overdose treatments